This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alksne, J. F. Articles by Branson, P. J. Search for Related Content PubMed PubMed Citation Articles by Alksne, J. F. Articles by Branson, P. J.

Stroke, Vol 10, 638-644, Copyright © 1979 by American Heart Association

ARTICLES

Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG- 626)

JF Alksne and PJ Branson

Experiments in monkeys have demonstrated that the chronic vasospasm and arterial injury reaction produced by subarachnoid blood injection can be prevented by treatment with the phosphodiesterase inhibitor phthalazinol. This protective effect, which is present even when the drug treatment is initiated after the subarachnoid blood injection, is presumed to occur because of the platelet inhibiting effect of phthalazinol.

This article has been cited by other articles:

				J. F. Alksne, P. J. Branson, and J. F. Alksne Prevention of Arterial Injury Reaction to Adventitial Blood with Intravenous Persantine Angiology, December 1, 1982; 33(12): 776 - 780. [PDF]